http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
InBrain Pharma Secures €1.8 Million in Funding for the PERCEPAR Project under France 2030’s “First Factory” Initiative to Industrialize Anaerobic Dopamine Production for Parkinson’s Disease
-
Culture, jazz and decision-making: The Economist's "Boss Class" podcast on management returns with season two
-
Breaking Boundaries: Coupa Trendsetter Award Winners Set A New Pace for Business Growth
-
Sun Sentinel Names Kaplan a Winner of the South Florida Top Workplaces 2025 Award, Marking its Fifth Consecutive Annual Recognition
-
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
-
Alisher Usmanov Wins Legal Case Against Luxembourg’s Largest Media Group, Says Law Firm Rechtsanwälte Steinhöfel
-
Upscale AI Launches With $5.5M in Funding and Unveils ‘Upscale Studio’ — the First AI-Native Platform to Create and Run Performance TV Ads on Streaming Channels
-
AITX Supports New OTCID Market Structure, Embraces Higher Standards
-
What Should You Document After a Motor Vehicle Collision in Florida to Support Your Claim for Injuries?
-
Visium Technologies and True Photonic Partner to Launch First AI-Optimized Smart City Platform on Pure Photonic Compute Infrastructure
-
Veradigm Advances GLP-1 Real-World Evidence Generation with AI-Driven EHR Data Curation
-
RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025
-
Canadian Gold Corp. Tartan South Zone Continues to Hit: 140m Vertical Expansion Intersects 9.4 gpt Gold/ 3.3m
-
Schneider Electric Unveils Innovations Advancing American Manufacturing at Automate 2025
-
Euro Manganese Announces Appointment of Ms. Martina Blahova as Permanent President & Chief Executive Officer
-
Bitget Delivers Critical Aid to Earthquake-Affected Families in Myanmar
-
Avant Technologies and Ainnova Tech Begin Acquisition Talks Ahead of FDA Pre-Submission Meeting
-
Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
-
UroGen Pharma Reports First Quarter 2025 Financial Results and Provides a Business Update
-
Avant Technologies and Ainnova Tech Begin Acquisition Talks Ahead of FDA Pre-Submission Meeting
-
Ainos Reports First Quarter 2025 Financial Results
-
DeFi Technologies (DEFI) Begins Trading on Nasdaq
-
BridgeBio to Present Clinical Outcomes, Quality of Life Measures and Incidence of Atrial Fibrillation Events in Patients with ATTR-CM from the ATTRibute-CM Study at the Annual Congress of the Heart Fa
-
DeFi Technologies Begins Trading on Nasdaq, Announces Shareholder Call to Discuss Q1 2025 Financial Results
-
Criterium Energy Announces 2024 Year End Results and Provides Operational Update
-
Nuwellis (NUWE) Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency
-
AB InBev SA (BUD) Announces $300M Investment in U.S. Manufacturing
-
Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
-
Lightbridge Provides Business Update and Announces First Quarter 2025 Financial Results
-
ANHEUSER-BUSCH ANNOUNCES NEW $300 MILLION INVESTMENT IN MANUFACTURING OPERATIONS ACROSS THE U.S.
-
Ispire Technology Inc. Reports Financial Results for Fiscal Third Quarter 2025
-
Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency
-
CytomX Therapeutics (CTMX) Reports Positive Interim Data From Phase 1 Dose Escalation Study of CX-2051
-
Fortrea (FTRE) Announces CEO Resignation
-
Fortrea Reports First Quarter 2025 Results
-
Fortrea Announces CEO Stepping Down
-
ImmunityBio Reports Doubled Net Revenue and 150% Unit Growth in Q1 2025, With Continued Strong Sales Momentum in First Quarter since J-code
-
Fortrea Announces CEO Stepping Down
-
Funding for Colosseum Project
-
CytomX Announces Positive Interim Data From Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) Candidate in Patients with Advanced Colorectal Cancer (CRC)
-
CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update
-
Cybersecurity Veteran Kevin Mandia joins DTEX’s Advisory Board
-
Consumers Energy's Summer Energy Forecast: Michigan's Grid Ready to Weather the Heat
-
GFG Discovers New Gold Zone in Footwall and Extends Mineralization to Near-Surface at Aljo Gold Project, Timmins, ON
-
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
-
Cooler Master Launches Hyper 612 APEX: Compact, High-Performance CPU Cooler for Modern Builds
-
Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages NET Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NPWR, NPWR.WS
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages UnitedHealth Group Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNH
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR
